Drug Research
Genomic Ties Announced By UK With Thailand On Health...
A new partnership with Thailand to share the expertise of genome sequencing, research collaboration, education and training opportunities, as well as genomics data handling will...
News
Digital media and ROI in Pharma
There was a pin-drop silence in the conference room. A senior executive from a multinational pharma company had asked me a question; “Which digital platform...
Drug Research
South Korean Pharma Sector Attracts Despite Drug Nod Delays
According to a survey from Fitch Solutions, South Korea's pharmaceutical market attractiveness is expected to stay strong despite ongoing concerns about the country's slow pace...
News
From February 13, FDA In-Person Session To Start Barring...
FDA has recently announced that it is going to restart its in-person meetings that are face-to-face beginning February 13 with industry sponsors of biologics and...
Drug Research
To Curb Medicine Inequality, 3-Year Novel Strategy Announced
A novel strategy for 2023–25 adopted by the Medicines Patent Pool looks to lessen the inequalities in access by way of enhancing the affordability as...
Drug Research
EC approves Regeneron-Sanofi’s Dupixent for eosinophilic esophagitis
The European Commission (EC) has granted marketing authorisation for Regeneron Pharmaceuticals and Sanofi’s Dupixent (dupilumab) to treat eosinophilic esophagitis (EoE).
Dupixent’s expanded authorisation in the European...
Drug Research
Seqens Group Opens Flagship Pharmaceutical R&D Center in Greater...
Seqens Group opens the Seqens Boston R&D Center, a state-of-the-art, 15,000 square-foot R&D center in Devens, Mass. that serves as one of the company’s global...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.